================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (date of earliest event reported): January 5, 2007
PEDIATRIX MEDICAL GROUP, INC.
-----------------------------
(Exact Name of Registrant as Specified in Its Charter)
Florida 001-12111 65-0271219
----------------------------- ------------------------ -------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
1301 Concord Terrace
Sunrise, Florida 33323
---------------------------------------
(Address of principal executive office)
Registrant's telephone number, including area code (954) 384-0175
================================================================================
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On January 5, 2007, the Company issued a press release (the "Press
Release") announcing an update with respect to its previously disclosed internal
voluntary review of its historical stock option practices. A copy of the Press
Release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is
hereby incorporated by reference in its entirety.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1-- Press Release dated January 5, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PEDIATRIX MEDICAL GROUP, INC.
Date: January 5, 2007 By: /s/ Karl B. Wagner
------------------------------
Name: Karl B. Wagner
Title: Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Description
99.1 Press Release dated January 5, 2007.